Carticel SM Service market seen growing on personalized medicine demand

The Carticel SM Service market is expanding as demand rises for personalized cartilage repair, regenerative medicine and orthopedic procedures, according to The Business Research Company. North America led the market in 2025, while Europe is expected to grow fastest through 2035.

Why it matters: - Carticel SM Service targets cartilage repair in patients with joint injuries and degenerative conditions, a need that rises with sports injuries, aging populations and osteoarthritis. - The market’s growth reflects broader demand for personalized medicine and regenerative treatments that use a patient’s own cells. - Wider use of these therapies could expand options for patients who have not responded to other cartilage repair treatments.

What happened: - The Business Research Company released its Carticel SM Service Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the market is gaining traction as cartilage repair advances and awareness of personalized treatment options grows. - North America held the largest share of the Carticel SM Service market in 2025. - Europe is expected to be the fastest-growing region during the forecast period.

The details: - Carticel SM Service is a specialized form of autologous chondrocyte implantation designed to repair damaged cartilage, especially in the knee. - The treatment uses the patient’s own cells to promote healing, tissue repair and improved joint function. - Historical growth has been supported by sports injuries, limited cartilage repair alternatives, progress in orthopedic surgery, hospital-based joint care and an aging population. - Future growth is expected to be supported by broader adoption of regenerative medicine, more orthopedic procedures, higher surgical success rates, growth in outpatient surgery centers and greater patient awareness. - Forecast-period trends include rising use of autologous cell therapy, more cartilage repair operations, growing interest in regenerative orthopedics, more joint preservation strategies and more specialty surgical centers. - The report identifies personalized medicine as a key driver because Carticel SM Service is tailored to individual biological needs. - Advances in genomics, artificial intelligence and biotechnology are accelerating personalized treatment development. - The Personalised Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. - Rising healthcare spending is also supporting demand for innovative biologic treatments. - The UK Office for National Statistics reported healthcare spending rose 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024, while healthcare’s share of GDP stayed at 11.1%. - The World Health Organization said in October 2024 that by 2030, one in six people globally will be aged 60 or older. - WHO also projected the population aged 60 and older will rise from 1 billion in 2020 to 1.4 billion in 2030 and 2.1 billion by 2050. - The population aged 80 and older is projected to triple by 2050 to about 426 million. - The report says the market covers Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East and Africa, alongside North America and Europe.

Between the lines: - The report points to a market shaped less by one breakthrough product and more by multiple tailwinds: demographics, procedure volume, spending and a shift toward biologic care. - North America’s lead suggests established reimbursement, infrastructure and adoption are still important for advanced regenerative therapies. - Europe’s faster projected growth suggests room for catch-up demand as regenerative orthopedics gains wider acceptance. - The report’s focus on specialty centers and outpatient surgery points to a broader shift in where cartilage repair is delivered.

What's next: - The forecast period runs through 2035, with the report highlighting continued gains in regenerative medicine, outpatient care and specialty orthopedic services. - The Business Research Company says its 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The company also offers a free sample report and the full report online at the sample report and the full market report.